4//SEC Filing
Corbus Pharmaceuticals Holdings, Inc. 4
Accession 0001209191-16-145416
$CRBPCIK 0001595097operating
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:52 PM ET
Size
5.6 KB
Accession
0001209191-16-145416
Insider Transaction Report
Form 4
Tepper Mark
President and CSO
Transactions
- Award
Stock Option(right to buy)
2016-10-06+150,000→ 150,000 totalExercise: $8.71Exp: 2026-10-06→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on October 6, 2017, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on November 6, 2017.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001595097
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 4:52 PM ET
- Size
- 5.6 KB